Since 2013, the ITOMIC triple negative breast cancer trial has been on the leading edge of where cancer advances are going... equipping physicians and patients with personalized information about how to treat their cancer. To date, 31 patients have been enrolled in the trial, 28 of whom are South Sound CARE patients. The ITOMIC trial has opened up an avenue for this innovative approach for patients with an incurable form of breast cancer. The study is getting international attention in scientific articles... and now in the New York Times.
Related Articles
At The Rush Companies, our tagline, "Building an Exceptional Future, Together," embodies our genuine dedication to creating a better future for...
Giving back continues to be an important part of who we are at Rush. In 2025, our team once again came together to support a wide range of...
At The Rush Companies, doing the right thing is woven into how we work, how we lead, and how we show up for one another every day.